Literature DB >> 17578415

Action of divergicin M35, a class IIa bacteriocin, on liposomes and Listeria.

K Naghmouchi1, D Drider, I Fliss.   

Abstract

AIMS: The mode of action of divergicin M35, a class IIa bacteriocin, was studied against Listeria monocytogenes with sensitive (DivS) and resistant (DivM) phenotypes, as well as on synthetic phospholipid liposomes. METHODS AND
RESULTS: Divergicin-induced release of 1,6-diphenyl-1,3,5-hexatriene (DPH) from zwitterionic (DMPC) and anionic (DMPC/DMPG, 4:1) liposomes, divergicin binding to liposomes, intracellular ATP concentration, cation efflux, cell affinity for hydrocarbons and cell lysis were measured and cell damage was visualized by fluorescence imaging and transmission electron microscopy. Divergicin M35 at 5 microg ml(-1) induced DPH efflux from anionic and zwitterionic liposomes at rates of about 2.58% and 1.61% per minute, respectively. DPH efflux rate from anionic liposomes was reduced by about 1.83% and 2.1% per minute in the presence of Li+ and Ca2+, respectively. Binding affinity of divergicin M35 to anionic and zwitterionic liposomes was about 86% and 63%, respectively. Intracellular ATP decreased in the sensitive and the resistant strains by 96.7% and 72.8%, respectively after 20 min of exposure to 5 microg ml(-1) divergicin M35. Lysis of the sensitive strain reached 57% in 18 h at a concentration of 5 microg ml(-1) when compared with the lysis of the divergicin-resistant strain (38.8%). The K+ and Na+ efflux from the divergicin-sensitive strain reached 87% and 80% of the total ion content within 5 min of exposure. This strain also showed higher affinity for hydrocarbons.
CONCLUSIONS: The cell death of listerial strains upon addition of divergicin M35 could result from ATP depletion, K+ and Na+ efflux, and bacteriolysis. This triple biological effect was attenuated in the DivM strain. SIGNIFICANCE AND IMPACT OF THE STUDY: This study contributed to the understanding of the mode of action of divergicin M35, a pediocin-like bacteriocin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578415     DOI: 10.1111/j.1365-2672.2006.03206.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  10 in total

1.  Lactocin 160, a Bacteriocin Produced by Vaginal Lactobacillus rhamnosus, Targets Cytoplasmic Membranes of the Vaginal Pathogen, Gardnerella vaginalis.

Authors:  Yevgeniy Turovskiy; Richard D Ludescher; Alla A Aroutcheva; Sebastian Faro; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2009-01-20       Impact factor: 4.609

2.  Membrane interactions of synthetic peptides with antimicrobial potential: effect of electrostatic interactions and amphiphilicity.

Authors:  Matthieu Fillion; Geneviève Valois-Paillard; Aurélien Lorin; Mathieu Noël; Normand Voyer; Michèle Auger
Journal:  Probiotics Antimicrob Proteins       Date:  2015-03       Impact factor: 4.609

3.  Expression of 4kD scorpion defensin and its in vitro synergistic activity with conventional antibiotics.

Authors:  Mingfu Niu; Xiang Li; Qiang Gong; Chen Wang; Cuili Qin; Wenhui Wang; Puyan Chen
Journal:  World J Microbiol Biotechnol       Date:  2012-09-30       Impact factor: 3.312

4.  Nisin A and Polymyxin B as Synergistic Inhibitors of Gram-positive and Gram-negative Bacteria.

Authors:  Karim Naghmouchi; Djamel Drider; John Baah; Ron Teather
Journal:  Probiotics Antimicrob Proteins       Date:  2010-06       Impact factor: 4.609

5.  Characterization of a bacteriocin produced by Lactococcus lactis subsp. lactis CRL 1584 isolated from a Lithobates catesbeianus hatchery.

Authors:  Sergio E Pasteris; Esteban Vera Pingitore; Cesar E Ale; María E Fatima Nader-Macías
Journal:  World J Microbiol Biotechnol       Date:  2013-10-23       Impact factor: 3.312

6.  Partial purification and characterization of the mode of action of enterocin S37: a bacteriocin produced by Enterococcus faecalis S37 isolated from poultry feces.

Authors:  Y Belguesmia; Y Choiset; H Prévost; M Dalgalarrondo; J-M Chobert; D Drider
Journal:  J Environ Public Health       Date:  2010-08-02

7.  Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q.

Authors:  Fuminori Yoneyama; Yuichi Imura; Kanako Ohno; Takeshi Zendo; Jiro Nakayama; Katsumi Matsuzaki; Kenji Sonomoto
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

Review 8.  Gut Microbiota is an Important Source of Bacteriocins and Their In Situ Expression Can Be Explored for Treatment of Bacterial Infections.

Authors:  Djamel Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2021-09-14       Impact factor: 4.609

Review 9.  A Review of the Latest Advances in Encrypted Bioactive Peptides from Protein-Rich Waste.

Authors:  Ailton Cesar Lemes; Luisa Sala; Joana da Costa Ores; Anna Rafaela Cavalcante Braga; Mariana Buranelo Egea; Kátia Flávia Fernandes
Journal:  Int J Mol Sci       Date:  2016-06-16       Impact factor: 5.923

10.  Lacticaseicin 30 and Colistin as a Promising Antibiotic Formulation against Gram-Negative β-Lactamase-Producing Strains and Colistin-Resistant Strains.

Authors:  Désiré Madi-Moussa; Yanath Belguesmia; Audrey Charlet; Djamel Drider; Françoise Coucheney
Journal:  Antibiotics (Basel)       Date:  2021-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.